Apellis Pharmaceuticals Inc (NASDAQ:APLS) Sellers Declined Their Shorts By 8.16%

May 16, 2018 - By Russell Jones

It was noted a decrease on Apellis Pharmaceuticals Inc (NASDAQ:APLS)’s shares shorted with 8.16%. In May was published APLS’s total 1.64M shares shorted by FINRA. The 1.79M previous shares are down with 8.16%. Previous APLS’s position will need 3 days to recover. It has 514,900 average volume. Apellis Pharmaceuticals Inc float short is 6.98%.

APLS is hitting $23.81 during the last trading session, after decreased 0.42%.Apellis Pharmaceuticals, Inc. has 331,999 shares volume, 34.39% up from normal. APLS is and has moved 0.00% since May 16, 2017. The stock underperformed the S&P500 by 11.55%.

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases.The firm is worth $1.33 billion. The Company’s lead product candidates include APL-2 and APL-1, to treat paroxysmal nocturnal hemoglobinuria, geographic atrophy, intermediate age-related macular degeneration, and chronic obstructive pulmonary disease.Last it reported negative earnings. The firm develops APL-2 for subcutaneous injection, which is an injection into the tissue under the skin, and for intravitreal injection that is an injection into the eye, as well as APL-1 for inhaled administration.

For more Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) news published recently go to: Globenewswire.com, Seekingalpha.com, Nasdaq.com, Fool.com or Globenewswire.com. The titles are as follows: “Apellis Pharmaceuticals Announces Closing of Offering of Common Stock” published on April 23, 2018, “Bright Lights On Capitalist Woodstock, Tech Developers And Sports Betting” on May 05, 2018, “Mid-Afternoon Market Update: Chinanet Gains Following Q4 Results; SeaChange Shares Fall” with a publish date: April 17, 2018, “Why GoPro, Apellis Pharmaceuticals, and Hertz Global Holdings Slumped Today” and the last “Apellis Pharmaceuticals Announces Pricing of Offering of Common Stock” with publication date: April 19, 2018.

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: